Neumann Capital Management, LLC Bristol Myers Squibb CO Transaction History
Neumann Capital Management, LLC
- $289 Million
- Q1 2025
A detailed history of Neumann Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Neumann Capital Management, LLC holds 18,273 shares of BMY stock, worth $880,393. This represents 0.39% of its overall portfolio holdings.
Number of Shares
18,273
Previous 19,773
7.59%
Holding current value
$880,393
Previous $1.12 Million
0.36%
% of portfolio
0.39%
Previous 0.37%
Shares
20 transactions
Others Institutions Holding BMY
# of Institutions
2,796Shares Held
1.61BCall Options Held
27.4MPut Options Held
28.1M-
Vanguard Group Inc Valley Forge, PA191MShares$9.22 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.64 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.21 Billion0.52% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.58 Billion0.22% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.2 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $102B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...